131 related articles for article (PubMed ID: 16757548)
1. Tissue-specific expression and regulation of GSK-3 in human skeletal muscle and adipose tissue.
Ciaraldi TP; Oh DK; Christiansen L; Nikoulina SE; Kong AP; Baxi S; Mudaliar S; Henry RR
Am J Physiol Endocrinol Metab; 2006 Nov; 291(5):E891-8. PubMed ID: 16757548
[TBL] [Abstract][Full Text] [Related]
2. Troglitazone but not metformin restores insulin-stimulated phosphoinositide 3-kinase activity and increases p110beta protein levels in skeletal muscle of type 2 diabetic subjects.
Kim YB; Ciaraldi TP; Kong A; Kim D; Chu N; Mohideen P; Mudaliar S; Henry RR; Kahn BB
Diabetes; 2002 Feb; 51(2):443-8. PubMed ID: 11812753
[TBL] [Abstract][Full Text] [Related]
3. Regulation of skeletal muscle morphology in type 2 diabetic subjects by troglitazone and metformin: relationship to glucose disposal.
Mathieu-Costello O; Kong A; Ciaraldi TP; Cui L; Ju Y; Chu N; Kim D; Mudaliar S; Henry RR
Metabolism; 2003 May; 52(5):540-6. PubMed ID: 12759881
[TBL] [Abstract][Full Text] [Related]
4. Potential role of glycogen synthase kinase-3 in skeletal muscle insulin resistance of type 2 diabetes.
Nikoulina SE; Ciaraldi TP; Mudaliar S; Mohideen P; Carter L; Henry RR
Diabetes; 2000 Feb; 49(2):263-71. PubMed ID: 10868943
[TBL] [Abstract][Full Text] [Related]
5. The primary defect in glycogen synthase activity is not based on increased glycogen synthase kinase-3alpha activity in diabetic myotubes.
Gaster M; Brusgaard K; Handberg A; Højlund K; Wojtaszewski JF; Beck-Nielsen H
Biochem Biophys Res Commun; 2004 Jul; 319(4):1235-40. PubMed ID: 15194499
[TBL] [Abstract][Full Text] [Related]
6. Troglitazone improves whole-body insulin resistance and skeletal muscle glucose use in type II diabetic patients.
Yokoyama I; Yonekura K; Moritan T; Tateno M; Momose T; Ohtomo K; Inoue Y; Nagai R
J Nucl Med; 2001 Jul; 42(7):1005-10. PubMed ID: 11438619
[TBL] [Abstract][Full Text] [Related]
7. Regulation of glucose transport and insulin signaling by troglitazone or metformin in adipose tissue of type 2 diabetic subjects.
Ciaraldi TP; Kong AP; Chu NV; Kim DD; Baxi S; Loviscach M; Plodkowski R; Reitz R; Caulfield M; Mudaliar S; Henry RR
Diabetes; 2002 Jan; 51(1):30-6. PubMed ID: 11756319
[TBL] [Abstract][Full Text] [Related]
8. Unlike insulin, amino acids stimulate p70S6K but not GSK-3 or glycogen synthase in human skeletal muscle.
Liu Z; Wu Y; Nicklas EW; Jahn LA; Price WJ; Barrett EJ
Am J Physiol Endocrinol Metab; 2004 Apr; 286(4):E523-8. PubMed ID: 14656717
[TBL] [Abstract][Full Text] [Related]
9. Short-term in vitro inhibition of glycogen synthase kinase 3 potentiates insulin signaling in type I skeletal muscle of Zucker Diabetic Fatty rats.
Henriksen EJ; Teachey MK
Metabolism; 2007 Jul; 56(7):931-8. PubMed ID: 17570255
[TBL] [Abstract][Full Text] [Related]
10. Troglitazone regulation of glucose metabolism in human skeletal muscle cultures from obese type II diabetic subjects.
Park KS; Ciaraldi TP; Abrams-Carter L; Mudaliar S; Nikoulina SE; Henry RR
J Clin Endocrinol Metab; 1998 May; 83(5):1636-43. PubMed ID: 9589670
[TBL] [Abstract][Full Text] [Related]
11. Dysregulation of glycogen synthase kinase-3 in skeletal muscle and the etiology of insulin resistance and type 2 diabetes.
Henriksen EJ
Curr Diabetes Rev; 2010 Sep; 6(5):285-93. PubMed ID: 20594161
[TBL] [Abstract][Full Text] [Related]
12. Diabetes and obesity during pregnancy alter insulin signalling and glucose transporter expression in maternal skeletal muscle and subcutaneous adipose tissue.
Colomiere M; Permezel M; Lappas M
J Mol Endocrinol; 2010 Apr; 44(4):213-23. PubMed ID: 19955252
[TBL] [Abstract][Full Text] [Related]
13. Modulation of circulating and adipose tissue adiponectin levels by antidiabetic therapy.
Phillips SA; Ciaraldi TP; Kong AP; Bandukwala R; Aroda V; Carter L; Baxi S; Mudaliar SR; Henry RR
Diabetes; 2003 Mar; 52(3):667-74. PubMed ID: 12606507
[TBL] [Abstract][Full Text] [Related]
14. Effects of troglitazone on cellular differentiation, insulin signaling, and glucose metabolism in cultured human skeletal muscle cells.
Kausch C; Krützfeldt J; Witke A; Rettig A; Bachmann O; Rett K; Matthaei S; Machicao F; Häring HU; Stumvoll M
Biochem Biophys Res Commun; 2001 Jan; 280(3):664-74. PubMed ID: 11162573
[TBL] [Abstract][Full Text] [Related]
15. GSK-3beta regulation in skeletal muscles by adrenaline and insulin: evidence that PKA and PKB regulate different pools of GSK-3.
Jensen J; Brennesvik EO; Lai YC; Shepherd PR
Cell Signal; 2007 Jan; 19(1):204-10. PubMed ID: 16934435
[TBL] [Abstract][Full Text] [Related]
16. Chronic selective glycogen synthase kinase-3 inhibition enhances glucose disposal and muscle insulin action in prediabetic obese Zucker rats.
Dokken BB; Henriksen EJ
Am J Physiol Endocrinol Metab; 2006 Aug; 291(2):E207-13. PubMed ID: 16478771
[TBL] [Abstract][Full Text] [Related]
17. Effects of adrenaline on whole-body glucose metabolism and insulin-mediated regulation of glycogen synthase and PKB phosphorylation in human skeletal muscle.
Jensen J; Ruge T; Lai YC; Svensson MK; Eriksson JW
Metabolism; 2011 Feb; 60(2):215-26. PubMed ID: 20153492
[TBL] [Abstract][Full Text] [Related]
18. Impaired insulin activation and dephosphorylation of glycogen synthase in skeletal muscle of women with polycystic ovary syndrome is reversed by pioglitazone treatment.
Glintborg D; Højlund K; Andersen NR; Hansen BF; Beck-Nielsen H; Wojtaszewski JF
J Clin Endocrinol Metab; 2008 Sep; 93(9):3618-26. PubMed ID: 18544618
[TBL] [Abstract][Full Text] [Related]
19. Tissue-specific role of glycogen synthase kinase 3beta in glucose homeostasis and insulin action.
Patel S; Doble BW; MacAulay K; Sinclair EM; Drucker DJ; Woodgett JR
Mol Cell Biol; 2008 Oct; 28(20):6314-28. PubMed ID: 18694957
[TBL] [Abstract][Full Text] [Related]
20. Insulin action and signalling in fat and muscle from dexamethasone-treated rats.
Burén J; Lai YC; Lundgren M; Eriksson JW; Jensen J
Arch Biochem Biophys; 2008 Jun; 474(1):91-101. PubMed ID: 18328801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
